Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Women with PCOS have thicker parafoveal areas in their retinas, but their macular blood vessel density is normal.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

The DNA convention was a valuable opportunity for learning and networking, especially after COVID-19.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Eating high-glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Red ginseng oil is believed to have various health benefits and is safe, but more research is needed to fully understand how it works.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Tiny particles called extracellular vesicles show promise for skin improvement and anti-aging in facial care but face challenges like low production and lack of research.

Microneedles are a promising method for drug delivery, offering efficient and convenient alternatives with fewer side effects.

Some women with PCOS have rare genetic variants linked to the condition.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Male pattern baldness does not cause an increased risk of prostate cancer.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.